Quantum Materials Announces Goals for Solar Energy Quantum Dot Integration
Mar 09, 2016 13:00 pm UTC| Business
NEWPORT BEACH, Calif., March 09, 2016 -- In a presentation today at the Smithers Apex’s 4th Annual Quantum Dots Forum in Newport Beach, California, Dr. Nathan Stott, Quantum Materials Corp Director of Materials,...
RedHill Biopharma to Present at the 28th Annual ROTH Conference
Mar 09, 2016 13:00 pm UTC| Business
TEL-AVIV, Israel, March 09, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL)(“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development and commercialization of late...
YY to Announce Fourth Quarter and Full Year 2015 Financial Results
Mar 09, 2016 13:00 pm UTC| Business
GUANGZHOU, China, March 09, 2016 -- YY Inc. (NASDAQ:YY) ("YY" or the “Company”), a revolutionary real-time interactive social platform, today announced that it plans to release its fourth quarter and full year 2015...
Mar 09, 2016 13:00 pm UTC| Business
SANTA CLARA, Calif., March 09, 2016 -- WHERE:Open Compute Project Summit, San Jose Convention Center, 150 West San Carlos Street, San Jose, Calif., 95113 WHEN:March 9 – 10, 2016 WHAT:Kumar Sankaran, associate vice...
Mar 09, 2016 13:00 pm UTC| Business
--Company Focused on Advancing Its Bavituximab Immuno-Oncology Program Through Its Pharmaceutical, Academic and Clinical Collaborations-- --Full Fiscal Year 2016 Revenue From Biomanufacturing Business, Avid Bioservices,...
Zosano Pharma to Present at the 28th Annual ROTH Conference
Mar 09, 2016 13:00 pm UTC| Business
FREMONT, Calif., March 09, 2016 -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced that Konstantinos Alataris, Ph.D., President and Chief Executive Officer of...
Spark Therapeutics Reports 2015 Financial Results and Business Highlights
Mar 09, 2016 13:00 pm UTC| Business
Following positive top-line results from pivotal Phase 3 trial of SPK-RPE65 for genetic blinding conditions, company significantly expands and advances gene therapy pipeline Begins 2016 with a cash position over $300...